Tag Archives: CML

December, 2017

November, 2017

July, 2017

January, 2017

  • 2 January

    FDA Grants Orphan Drug Status to Escend Pharma’s ES-3000 for AML

    Menlo Park, CA, December 28, 2016/PRNewswire/ — Escend Pharmaceuticals, Inc., a privately held company focused on the development of small molecule therapeutics for oncology orphan diseases, announced today that the FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation for its lead product candidate, ES-3000, for the treatment …

December, 2016

December, 2015

  • 4 December

    FDA Approves Sun Pharma’s Generic Gleevec

    Mumbai, December 04, 2015: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharma) today announced that one of its subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Gleevec®, Imatinib Mesylate tablets 100mg and …